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Abstract 26 
 The largest plasmid in the strain 39R861, which is used as a plasmid size 27 
standard, was recovered by conjugation and sequenced to determine its exact size. 28 
Plasmid p39R861-4 transferred at high frequency. Though reported to be the A/C1 29 
plasmid RA1, p39R861-4 is a 155794 bp Type 2 A/C2 plasmid in which a 39 kb 30 
segment derived from RA1 that includes a relative of the RA1 resistance island replaces 31 
26.5 kb of the Type 2 backbone. p39R861-4 includes a single copy of IS10 and two 32 
resistance islands with a CR2-sul2 region in each of them. The 84 kb of backbone 33 
between the resistance islands is inverted relative to other known A/C plasmids and this 34 
inversion has arisen via recombination between the CR2-sul2 regions that are inversely 35 
oriented. The resistance islands prior to inversion were one related to but longer than 36 
that found in RA1, and a form of the ARI-B island identical to one found in the A/C2 37 
plasmid R55. They contain genes conferring resistance to tetracycline (tetA(D)), 38 
sulphonamides (sul2) and florfenicol and chloramphenicol (floR). The tet(D) 39 
determinant is flanked by two IS26 in a transposon-like structure named Tntet(D). Both 40 
resistance islands contain remnants of the two ends of the integrative element GIsul2, 41 
consistent with the sul2 gene being mobilized by GIsul2 rather than by CR2.  42 
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Introduction 51 
Escherichia coli strain 39R861 was constructed prior to 1986 as a plasmid size 52 
standard20 and is routinely used to measure the size of closed circular plasmids. The four 53 
plasmids it carries are reported to be the IncA/C reference plasmid RA1, plasmid X, the 54 
IncW plasmid pSa and NTP168, with sizes of 154 kb, 66 kb, 38 kb and 7 kb, 55 
respectively, calculated from original size estimates of 98, 42, 23.9 and 4.6 MDa, 56 
respectively.21 Despite ongoing use as a standard, the size of each plasmid has never 57 
been precisely determined. RA1 is the only plasmid said to be present in 39R861 that 58 
has been sequenced (GenBank accession number FJ705807).10 The size of pSa can be 59 
estimated to be 40.1 kb from the IncW R388 sequence (GenBank accession number 60 
BR000038) and the sequence of the pSa integron (GenBank accession number 61 
NG_036033). 62 
Plasmids of the A/C group were among the earliest plasmids associated with 63 
antibiotic resistance in Gram-negative bacteria. Plasmid RA1 was recovered in 1971 64 
from the fish pathogen Aeromonas liquafaciens1 and is the IncA reference.5 RA1, 65 
carrying sul2 and tet(D), and a deletion derivative RAx were sequenced in 2009.10 The 66 
sequenced version of RA1 appears to have an IS26-mediated deletion within its 67 
resistance island relative to RAx (see Figure 5 in reference 12). RAx also appears to 68 
have acquired the aphA1 kanamycin and neomycin resistance determinant in a 2.9 kb 69 
insertion (bases 32533-35414 in GenBank accession number FJ705806) that is bounded 70 
by 24 bp perfect inverted repeats (IR) and flanked by 9 bp direct repeats (DR).12 This 71 
region is not found in RA1. Both of these differences are likely to have arisen after the 72 
initial isolation. 73 
A/C plasmids are now designated A/C1 or A/C2 based on the sequence of their 74 
backbones which share only 85-94% identity at the DNA level.10 RA1 is the only 75 
sequenced native A/C1 plasmid, whilst A/C2 is represented by over 65 complete plasmid 76 
sequences in GenBank (4th April 2015). The A/C2 plasmids can be further divided into 77 
two distinct types, Type 1 and Type 2 that have diverged via the accumulation of SNPs, 78 
via two regions of replacement internal to large open reading frames, and via the 79 
accumulation of insertions or deletions within the backbone.11 Many A/C2 plasmids 80 
include one or more islands made up of multiple genes conferring resistance to 81 
antibiotics. Some A/C2 plasmids of both types carry a resistance island, ARI-B, which 82 
always contains the sulphonamide resistance determinant sul2 and part or all of the 83 
small mobile element CR2, and can contain additional IS26-associated resistance 84 
genes.11-13,15,22 85 
Here, we have recovered the A/C plasmid from 39R861 by conjugation, 86 
determined its sequence and compared it to the available RA1 and A/C2 sequences. 87 
 88 
Materials and methods 89 
Bacterial strains and conjugation 90 
Plasmid p39R861-4 was transferred from E. coli 39R86120 to a rifampicin 91 
resistant derivative of E. coli UB5201 (pro met recA56 gyrA)14 by mixing equal amounts 92 
of stationary phase cultures on L-agar and growth overnight at 37oC. Cells were 93 
resuspended in 0.9% (w/v) sterile saline, serially diluted, and transconjugants recovered 94 
on plates containing rifampicin to select against the donor and for the recipient, and 95 
sulfamethoxazole (Su) to select for transfer of RA1 and pSa. SuR transconjugants were 96 
screened for resistance to tetracycline (Tc), chloramphenicol (Cm), florfenicol (Fl), 97 
kanamycin (Km), streptomycin (Sm) and spectinomycin (Sp), and for the presence of 98 
plasmid replicons using PCR-based Replicon Typing (PBRT) as described previously.16 99 
A transconjugant containing both an A/C and an F replicon (plasmid X) was further 100 
mated with E. coli UB1637 (SmR) to separate the two plasmids. The resulting 101 
transconjugants were screened using PBRT and their resistance phenotypes determined 102 
by patching onto plates containing Cm, Fl, Tc and Su. A CmRFlRSuRTcR transconjugant 103 
containing only the A/C replicon was mated with UB5201 (RifR) to determine its 104 
transfer frequency. Conjugation frequencies were calculated as the number of 105 
transconjugants per donor from three independent determinations.  106 
 107 
Polymerase chain reaction  108 
Polymerase chain reactions (PCR) were performed on approximately 20 ng of 109 
diluted plasmid DNA. PCR conditions were as described previously.24 Published 110 
primers2 were used to detect antibiotic resistance genes. Amplicons were resolved by 111 
electrophoresis on 1% (w/v) agarose gels with molecular weight standards, stained with 112 
ethidium bromide, and visualized using a GelDoc1000 image analysis station (BioRad). 113 
 114 
Plasmid recovery and sequencing  115 
Total plasmid DNA was extracted and sequenced on an Ion Torrent platform 116 
(Life Technologies) as previously described.11 The sequencing reads (62-fold coverage) 117 
were assembled de novo into contigs using Geneious version 6.1.6 (Biomatters). PCR 118 
and sequencing was used to join contigs that had separated on repeated sequences, 119 
namely IS4321, IS26, sul2 and CR2. Primers are listed in Table S1. Overlapping contigs 120 
were assembled with Sequencher version 5.1 (Gene Codes). The final assembly was 121 
confirmed by comparing the fragments obtained from an in silico BamHI or EcoRI 122 
digest to the fragments obtained when p39R861-4 was digested using BamHI or EcoRI 123 
(New England Biolabs). Residues missing from the majority of reads but present in 124 
some were assumed to be due to the use of the Ion Torrent platform, and corrected. 125 
Sequence analysis 126 
The backbone of p39R861-4 was derived by removing the antibiotic resistance 127 
regions and the insertion sequence (IS10) from the plasmid sequence and compared to 128 
the R55 (GenBank accession number JQ010984) and RA1 (GenBank accession number 129 
FJ705807) backbones, which were derived in the same way. Sequences were 130 
circularized and reopened at the same location, 1,139 bp upstream of repA. Pairwise 131 
comparisons using the BLAST paired alignment facility (http://blast.ncbi.nlm.nih.gov) 132 
were visualized using Artemis Comparison Tool.4  133 
Potential coding regions in p39R861-4 were identified and annotated based on 134 
the available annotations for the A/C plasmids R55 (GenBank accession number 135 
JQ010984), RA1 (GenBank accession number FJ705807), pRMH760 (GenBank 136 
accession number KF976462), and others.9,12 Gene Construction Kit version 2.5 137 
(Textco) was used to create figures to scale. 138 
Nucleotide sequence accession number   139 
The 155,794 bp nucleotide sequence of p39R861-4 was submitted to GenBank 140 
under accession no. KP276584. 141 
 142 
Results 143 
p39R861-4 is not RA1 144 
The A/C plasmid p39R861-4 was separated from the other plasmids carried in 145 
39R861 by conjugation (see Methods). Transconjugants that carried only an A/C 146 
plasmid had acquired resistance to sulfamethoxazole and tetracycline and contained sul2 147 
and tet(D) as expected for RA1. However, these transconjugants were also resistant to 148 
chloramphenicol and florfenicol, and the floR gene conferring resistance to these 149 
antibiotics is also carried on p39R861-4, though it is not present in RA1. Hence, the A/C 150 
plasmid in 39R861 is not RA1 as previously reported.20 The average frequency of 151 
transfer of p39R861-4 from an E. coli donor to an E. coli recipient was 4.21 x 10-2 (2.81 152 
x 10-2 – 6.88 x 10-2; three independent determinations) transconjugants per donor. 153 
 154 
 Sequence of p39R861-4 155 
The complete p39R861-4 sequence determined here (GenBank accession no. 156 
KP276584) was 155,794 bp, and p39R861-4 contains two resistance regions (RI-1 and 157 
RI-2 in Figure 1A) and a single copy of IS10. Removal of these insertions generated a 158 
backbone of 129,998 bp (Fig. 1A) that includes a replication gene (repA), genes for 159 
conjugative transfer (tra), partitioning (par), and a variety of other genes that have been 160 
described elsewhere12 or open reading frames with no known function. However, only 161 
26,559 bp of the p39R861-4 backbone was derived from RA1. Bases 44888 to 67672 162 
and 139973 to 143746 of pR39861-4 (GenBank accession number KP276584) share 163 
99.9% nucleotide identity (two SNPs) with bases 90443 to 113228 and 126346 to 164 
130120 of RA1 (GenBank accession number FJ705807). In RA1, these two segments 165 
flank the region that includes the resistance genes sul2 and tet(D) (RI-RA1 in Figure 166 
1B). The remainder of p39R861-4 includes the repA gene found in A/C2 plasmids, and 167 
shares 99.9% nucleotide identity (eight SNPs) with bases 1 to 30502, 39489 to 100362, 168 
and 158764 to 170810 of the type 2 A/C2 plasmid R55 (GenBank accession number 169 
JQ010984). Of the eight SNPs identified between p39R861-4 and R55, four are unique 170 
to R55 (i.e. not found in any other Type 2 A/C2 plasmid) and four are unique to 171 
p39R861-4. 172 
The RA1-derived portion of p39R861-4 is continuous in RA1 (Fig. 1B), 173 
interrupted only by RI-RA1, and the R55-derived portion is continuous in R55. An 174 
inversion in p39R861-4 has split and separated these continuous regions (Fig. 1A).  175 
 176 
Resistance islands in p39R861-4 177 
The first resistance island in p39R861-4 (RI-1 in Fig. 1) is 14,379 bp long and 178 
carries genes conferring resistance to chloramphenicol and florfenicol (floR), and 179 
sulphamethoxazole (sul2) (Fig. 2A). The second island (RI-2) is 10,088 bp and contains 180 
tetracycline (tetA(D)) and sulphonamide (sul2) resistance genes (Fig. 2A). The inversion 181 
described above appears to have occurred via homologous recombination between 182 
inversely oriented copies of CR2-sul2, one in ARI-B of the R55-derived segment and 183 
one in the RI in the RA1-derived segment (Fig. 2). The resistance islands in the 184 
configuration presumed to have existed prior to the inversion are shown in Fig. 2B. The 185 
island labeled ARI-B is identical to ARI-B in the Type 2 A/C2 plasmid R55 (GenBank 186 
Accession no. JQ010984)7 which contains the florfenicol resistance determinant floR. 187 
The second island is closely related to RI-RA1* (Fig. 2C), differing only by the 188 
inversion of the segment located between IS26-1 and IS26-3 that placed the two sul2 189 
genes in inverse orientation. We believe RI-RA1* is the likely progenitor of the islands 190 
seen in the sequenced RA1 and RAx plasmids. The RI-RA1* island (Fig. 2C) contains 191 
IS4321 and IS5075 flanking a copy of IS26 and a partial copy of tnpA5051. An IS26-192 
mediated deletion has removed 11 bp from the one end of IS4321. RI-RA1* contains a 193 
4,372 bp fragment of the sul2 end of GIsul2 and two copies of IS26 flanking tetA(D) in a 194 
5,166 bp transposon-like structure we have named Tntet(D). A 550 bp fragment between 195 
resG and IS26-2 does not share identity with any other sequence in GenBank.  196 
Origin of ARI-B 197 
 The extent of ARI-B in the p39R861-4 precursor and in R55 was 198 
determined by comparison with pRMH760 (GenBank accession number KF976462) 199 
which has a complete backbone. The plasmid backbone surrounding ARI-B in R55 and 200 
in the p39R861-4 precursor was complete, and the island had inserted precisely into the 201 
A/C backbone using a conservative mechanism (Fig. 3). ARI-B contains both the int and 202 
sul2 ends of the integrative element GIsul217 at its extremities (Fig. 3A). Alignment of 203 
the sul2 and int ends of the island with the intact backbone of pRMH760 (Fig. 3B) 204 
revealed that only three bases from the backbone (GGGA, bases 30067-30070 in 205 
GenBank accession number KF976462) were found at both the left and right boundaries 206 
of the island. However, as GIsul2 is an integrating element, one GGGA is derived from 207 
the A/C backbone and the second from GIsul2, and the recombination crossover has 208 
occurred within this span. A subsequent event has presumably led to loss of the internal 209 
portion of GIsul2.  210 
In addition, ARI-B in p39R861-4 also includes an insertion containing the 211 
florfenicol resistance determinant floR and a truncated copy of the small mobile element 212 
CR2. This segment appears to have been incorporated via homologous recombination 213 
with a 3,482 bp circle containing Δ2CR2. The two partial copies of CR2, ΔCR2 (802 bp) 214 
and Δ2CR2 (640 bp), have only retained bases from the previously defined19,24 ori end 215 
of CR2.  216 
 217 
Discussion 218 
 Here, sequencing of p39R861-4 has shown that the A/C plasmid in the sizing 219 
standard 39R861 is not RA1 as previously believed. Instead, it is a hybrid that has 220 
formed initially via the integration of a segment of RA1 into a Type 2 A/C2 plasmid 221 
identical or closely related to R55. This was followed by large inversions in and between 222 
the two resistance regions derived from R55 and RA1. Thus, p39R861-4 is the first 223 
sequenced example of hybrid formation between an A/C1 and an A/C2 plasmid.  224 
The precise origin of the hybrid p39R861-4 plasmid is unknown. However, early 225 
incompatibility and entry-exclusion experiments reported the recovery of recombinant 226 
plasmids formed between RA1 and R57b.5  R57b was isolated in Paris around the same 227 
time as R55,23 and is likely to be closely related or even identical to R55. A subsequent 228 
study reported the isolation of a spontaneous RA1 recombinant, named RA1-1, that was 229 
resistant to tetracycline, sulphonamides and chloramphenicol.6 This resistance 230 
phenotype can be accounted for by the floR, sul2 and tet(D) resistance genes identified 231 
here in the resistance islands of p39R861-4. It seems possible that p39R861-4 originated 232 
from these early experiments.  233 
  We propose that ARI-B in A/C2 plasmids formed first by incorporation of a 234 
complete GIsul2 into the A/C2 backbone, followed by loss of the central region and then 235 
acquisition of other variable segments (Fig. 3A) or loss of the int end and adjacent DNA. 236 
Some A/C2 plasmids contain a segment from the sul2 end of GIsul2 with a full copy of 237 
CR2 and the adjacent resG gene,13,17 whilst others retain a smaller segment with only a 238 
partial copy of CR2. In the case of ARI-B in R55 and the p39R861-4 precursor, floR in 239 
ARI-B appears to have been acquired via homologous recombination with a circle 240 
containing CR2Δ, rather than as a transposon as previously reported.8  241 
The close association between CR2 and sul2 led to the belief that CR2 may be 242 
responsible for the mobilization of sul2.18,19 However, it is now known that sul2-CR2 243 
can be found close to one end of a larger 15 kb structure called GIsul2, an integrating 244 
element that targets the 3’-end of the guaA gene found in bacterial chromosomes.17 245 
GIsul2 has been found in a number of bacterial species, including an Enterobacter 246 
cloacae strain recovered in the 1890’s.17 In the course of this analysis, we have found a 247 
complete copy of GIsul2 in additional genomes of Providencia stuartii strain ATCC 248 
33672 (GenBank accession number number CP008920) and Achromobacter 249 
xylosoxidans strain ATCC 27061 (GenBank accession CP006958). We also found a 250 
complete copy of GIsul2 in the IncX plasmid R485 (GenBank accession number 251 
HE577112)3 and in an unnamed B/O plasmid (GenBank accession number HG428756), 252 
though it was not identified at the time. Hence, it is now evident that sul2 is being 253 
mobilized by GIsul2, rather than by the small mobile element CR2.  254 
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 333 
Figure legends 334 
FIG. 1 Comparison of the p39R861-4 backbone with RA1 and R55. (A) p39R861-4 335 
backbone structure with regions derived from RA1 and R55 indicated above. Regions 336 
shared with RA1 are denoted by shading. Vertical arrows indicate the location of the RI-337 
1 and RI-2 resistance islands and a copy of IS10. The backbone is drawn to scale from 338 
GenBank accession number KP276584, with lengths in kb shown above the line. (B) 339 
RA1 and R55 backbones drawn to scale from GenBank accession numbers FJ705807 340 
and JQ010984, respectively. Vertical arrows indicate the location of the RI-RA1 341 
resistance island in RA1, and the ARI-B and RI-R55 resistance islands in R55. The 342 
region of the R55 backbone replaced in p39R861-4 is shown below. Regions containing 343 
genes involved in plasmid replication (rep), methylation (dcm), partitioning (par), 344 
transfer (tra) and the ybaA, uvrD, rhs2 genes are indicated by arrows below the line. 345 
 346 
FIG. 2. Evolution of p39R861-4. (A) Final p39R861-4 structure, (B) structure prior to 347 
inversion between two oppositely-oriented copies of sul2-CR2, and (C) original 348 
structure of RI-RA1* prior to inversion between two oppositely-oriented copies of IS26. 349 
Dashed lines denote backbone derived from R55, and dotted lines denote backbone 350 
derived from RA1. Genes and ORFs are indicated by horizontal arrows showing the 351 
direction of transcription. Resistance islands, denoted by RI-1, RI-2, ARI-B and RI-352 
RA1*, are drawn to scale. ISs and the small mobile element CR2 are shown as open 353 
boxes with a vertical bar indicating the ori end of CR2. IS numbers or names are 354 
indicated inside the box. The three copies of IS26 are numbered. Segments derived from 355 
GIsul2 and Tntet(D) are marked.  356 
 357 
FIG. 3. Mobilization of sul2 into the A/C2 backbone. (A) Insertion of ARI-B into the 358 
A/C2 backbone. The backbone is drawn to scale from pRMH760 (GenBank accession 359 
number KF976462), ARI-B from R55 (JQ010984) and GIsul2 from GenBank accession 360 
number CP001918. The small mobile element CR2 is shown as an open box with a 361 
vertical bar indicating the ori end of CR2. Genes and ORFs are shown as horizontal 362 
arrows indicating the direction of transcription. Regions in ARI-B derived from GIsul2 363 
are indicated by shading. (B) Precise bases associated with the mobilization of sul2. 364 
Bases at the int (bases 30477 to 30546 from GenBank accession number KP276584) and 365 
sul2 (bases 129913 to 129844 from GenBank accession number KP276584) ends of 366 
ARI-B are aligned with the intact backbone of pRMH760 (bases 30039 to 30108 from 367 
GenBank accession number KF976462). Bases found at both boundaries of the island 368 
are shown in bold. Shared bases are denoted by vertical lines.  369 
